| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope-Modified DNA Vaccine Immunization. | Cancer Immunol Res | 2015 | 0.89 |
| 2 | Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-labeled Pembrolizumab. | J Nucl Med | 2016 | 0.87 |